RSS

Sygnature Discovery

A strategic alliance between Sygnature Discovery, provider of integrated drug discovery resource and expertise, and ApconiX, non-clinical safety strategies and ion channel screening experts, has been announced. more

News

UK-based independent drug discovery expert and research partner, Sygnature Discovery, and University College London (UCL) School of Pharmacy have formed a partnership for a £1 million pancreatic cancer research project. more

News

The Queen’s Awards for Enterprise are prestigious awards given to companies for outstanding achievements in four categories. Here we briefly run through some of this year’s winners in the fields of innovation and international trade. more

News

Sygnature Discovery, UK provider of integrated drug discovery resource and expertise, has been ranked in the Financial Times list of Europe’s fastest growing companies, FT1000. more

News

Dr. Paul Clewlow, Sygnature Discovery, talks to EPM about the company’s successful track record in discovering medicines for the benefit of “patients with debilitating diseases such as cancer” more

Opinion

​Sygnature Discovery has successfully delivered a drug candidate to Corcept Therapeutics. more

News